BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20511546)

  • 1. Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells.
    Vosskuhl K; Greten TF; Manns MP; Korangy F; Wedemeyer J
    J Immunol; 2010 Jul; 185(1):119-25. PubMed ID: 20511546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth.
    Oldford SA; Haidl ID; Howatt MA; Leiva CA; Johnston B; Marshall JS
    J Immunol; 2010 Dec; 185(11):7067-76. PubMed ID: 21041732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha.
    Sher A; Oswald IP; Hieny S; Gazzinelli RT
    J Immunol; 1993 May; 150(9):3982-9. PubMed ID: 8473745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions.
    Tsujimoto H; Uchida T; Efron PA; Scumpia PO; Verma A; Matsumoto T; Tschoeke SK; Ungaro RF; Ono S; Seki S; Clare-Salzler MJ; Baker HV; Mochizuki H; Ramphal R; Moldawer LL
    J Leukoc Biol; 2005 Oct; 78(4):888-97. PubMed ID: 16033815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
    Hunter CA; Chizzonite R; Remington JS
    J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
    Wang J; Sun R; Wei H; Dong Z; Tian Z
    Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma.
    Choi BK; Kim YH; Kim CH; Kim MS; Kim KH; Oh HS; Lee MJ; Lee DK; Vinay DS; Kwon BS
    J Immunol; 2010 Aug; 185(3):1404-11. PubMed ID: 20610645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
    Vahlne G; Becker S; Brodin P; Johansson MH
    Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA.
    Berger M; Ablasser A; Kim S; Bekeredjian-Ding I; Giese T; Endres S; Hornung V; Hartmann G
    J Immunother; 2009 Apr; 32(3):262-71. PubMed ID: 19242374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of NK cell activation by tumor cells on antigen-specific antibody responses.
    Koh CY; Yuan D
    J Immunol; 1997 Nov; 159(10):4745-52. PubMed ID: 9366398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell.
    Manna PP; Chakrabarti G; Bandyopadhyay S
    Vaccine; 2010 Jan; 28(3):803-10. PubMed ID: 19879234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
    Marshall JD; Heeke DS; Abbate C; Yee P; Van Nest G
    Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.
    Lion E; Smits EL; Berneman ZN; Van Tendeloo VF
    Leuk Res; 2009 Apr; 33(4):539-46. PubMed ID: 18845337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-gamma secretion and not restricted to T and NK cells.
    Thibodeaux DK; Hunter SE; Waldburger KE; Bliss JL; Trepicchio WL; Sypek JP; Dunussi-Joannopoulos K; Goldman SJ; Leonard JP
    J Immunol; 1999 Nov; 163(10):5257-64. PubMed ID: 10553047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.